- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06292767
Cardiopulmonary Bypass on Mechanical Power and Postoperative Pulmonary Complications
The Impact of Two Different Mechanical Ventilation Strategies During Cardiopulmonary Bypass on Mechanical Power and Postoperative Pulmonary Complications
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients will be taken to the operating table after preoperative evaluation. Routine monitoring and routine anesthesia method will be applied to the patient. Access will be made through the radial artery for arterial catheterization. Patients will be ventilated with 6-8 ml/kg tidal volume, 12-14 frequency/min, 5 Positive end expiratory pressure(PEEP), 60% Fraction of inspired oxygen(FiO2) and oxygen saturation over 94. End tidal Carbon dixide(CO2) will be kept in the range of 32-37. After cardiac catheterizations are performed, the pump will be entered, and after all preparations are completed, an aortic cross-clamp will be placed and cardioplegic solution will be sent. After the patient enters the pump at full flow; Group 1: Non-ventilated patient group. Here, patients will be placed in the cardiac bypass mode of the anesthesia machine. Only 150 ml of free air flow will be provided and mechanical ventilation will be turned off.
Group 2: Patients will continue to be ventilated at FiO2: 40%, TV: 3 ml/kg, frequency 12 breaths/min, peep: 5 cm/H2O.
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
İnclusion criteria:
- Patients who will undergo elective cardiopulmonary bypass surgery and agree to participate in the study
- Patients who will undergo coronary or valve surgery
- Surgeries performed on a stopped heart
- Patients over 18 years
Exclusion criteria:
- Patients undergoing emergency cardiac surgery
- Patients who will undergo redo surgery
- Patients who will undergo total circulatory arrest surgery
- Patients in a state of preoperative shock
- Patients with acute and chronic hypoxemia (PaO2 <65mmHg, SpO2 <95 in room air)
- Patients followed with mechanical ventilation for 7 days before surgery
- Patients with BMI>35
- Patients with obstructive sleep apnea syndrome
- Patients with pulmonary artery pressure >50 mmHg
- Patients with glomerular filtration rate <30 ml/min
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Not ventilated
Non-ventilated patient group.Patients will be placed in the cardiac bypass mode of the anesthesia machine.
Only 150 ml of free air flow will be provided and mechanical ventilation will be turned off.
|
Mechanical Power= 0.098×Minute ventilation× (peak pressure - 0.5 (plato pressure-PEEP)).
These parameters are monitored on the monitor while the patient is mechanically ventilated and placed into the equation
|
Ventilated
Patients will continue to be ventilated at Fraction of inspired oxygen(FiO2): 40%, Tidal volume(TV): 3 ml/kg, frequency 12 breaths/min, Positive end expiratory pressure (Peep): 5 cm/H2O.
|
Mechanical Power= 0.098×Minute ventilation× (peak pressure - 0.5 (plato pressure-PEEP)).
These parameters are monitored on the monitor while the patient is mechanically ventilated and placed into the equation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mechanical power
Time Frame: intraoperative
|
mechanical power=0.098*minute
ventilation *(Ppeak-0.5*(Pplato-PEEP)
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mechanical power
Time Frame: postoperative in intensive care unit
|
mechanical power=0.098*minute
ventilation *(Ppeak-0.5*(Pplato-PEEP)
|
postoperative in intensive care unit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/462
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Methodist Health SystemCompletedHospital-acquired Pneumonia | Ventilator-associated PneumoniaUnited States
Clinical Trials on mechanical power calculation
-
Ayse UlgeyNot yet recruitingVentilator-induced Lung InjuryTurkey
-
Bozok UniversityCompletedMechanical Ventilation Complication | Aediatric AnesthesiaTurkey
-
University of WashingtonÖssur EhfCompletedTransfemoral AmputationUnited States
-
University Hospital, Basel, SwitzerlandTerminated
-
Kasr El Aini HospitalCompleted
-
Taipei Medical University HospitalCompletedRenal Insufficiency | MoralityTaiwan
-
Singapore National Eye CentreSingapore Eye Research InstituteCompleted
-
Guy's and St Thomas' NHS Foundation TrustUnknown
-
Institut National de la Santé Et de la Recherche...UnknownMechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study (SEP-BIO-PROG)Multiple SclerosisFrance